Dr. Roshanak Monzavi MD Pediatric Endocrinologist
Dr. Roshanak Monzavi is a pediatric endocrinologist in Los Angeles, California. She is affiliated with multiple hospitals in the area, including Children's Hospital Los Angeles and White Memorial Medical Center. She received her medical degree from University of California, Irvine School of Medicine and has been in practice for 16 years. She is one of 11 doctors at Children's Hospital Los Angeles and one of 3 at White Memorial Medical Center who specialize in Pediatric Endocrinology.
Are you Dr. Roshanak Monzavi? Claim your profile to make edits or add details. Claim/Edit Profile
Specialty & Clinical Interests
Pediatric Endocrinologist: General Pediatric Endocrinology
Education & Medical Training
University of California at Irvine
Residency, Pediatrics, 1998 - 2001
Children's Hospital of Los Angeles
Fellowship, Pediatric Endocrinology, 2002 - 2004
University of California, Irvine School of Medicine
Class of 1998
Certifications & Licensure
American Board of Family Medicine
Certified in Family Medicine
American Board of Family Medicine
Certified in Sports Medicine
FL State Medical License
Active through 2014
Publications & Presentations
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial.
Rigby, M. R.,Dimeglio, L. A.,Rendell, M. S.,Felner, E. I.,Dostou, J. M.,Gitelman, S. E.,Patel, C. M.,Griffin, K. J.,Tsalikian, E.,Gottlieb, P. A.,Greenbaum, C. J.,Sherry, N. A.,Moore, W. V.,Monzavi, R.,Willi, S. M.,Raskin, P.,Moran, A.,Russell, W. E.,Pinckney, A.,Keyes-Elstein, L.,Howell, M.,Aggarwal, S.,Lim, N.,Phippard, D.,Nepom, G. T.,McNamara, J.,Ehlers, M. R.
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
Orban, T., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Gottlieb, P. A., Greenbaum, C. J., Marks, J. B., Monzavi, R., Moran, A., Raskin, P., Rodriguez, H., Russell, W. E., Schatz, D., Wherrett, D., Wilson, D. M., Krischer, J. P., Skyler, J. S.
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.
Wherrett, D. K., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Marks, J. B., Monzavi, R., Moran, A., Orban, T., Palmer, J. P., Raskin, P., Rodriguez, H., Schatz, D., Wilson, D. M., Krischer, J. P., Skyler, J. S.
- Aetna Choice POS II
- Aetna HMO
- Anthem HealthKeepers HMO/POS
- Anthem KeyCare PPO
- BCBS Blue Card PPO
- CIGNA HMO
- CIGNA Open Access
- CIGNA PPO
- Coventry Carelink Health Plans PPO
- Coventry Virginia - HMO
- First Health PPO
- Great West PPO
- Humana ChoiceCare Network PPO
- Multiplan PHCS PPO
- Multiplan PPO
- United Healthcare - Direct Choice Plus POS
- United Healthcare - Direct Options PPO
Help Us Keep the "U.S. News Doctor Finder" Current
If you are aware of information on this pagethat is out of date or incorrect, please let us know.
*Required Field | Your email will not be used for marketing.
Your Message Has Been Submitted
As part of our research on the correction you submitted, you may be contacted at the email address provided.
Sorry, Your Message Could Not Be Submitted
Please try again later, or E-mail your message to email@example.com and include the Web address (URL) of the page that contains incorrect information.
4650 W Sunset Blvd
Los Angeles, CA 90027
Phone: (323) 669-4606
Fax: (323) 664-0337